Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MICRO-X LIMITED Capital/Financing Update 2019

Jun 12, 2019

65388_rns_2019-06-12_6e2511eb-bd5f-43ac-8fa2-fd642523bbac.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

Micro-X Limited, 1284 South Road, Tonsley, South Australia, 5042

ABN: 21 153 273 735

==> picture [127 x 37] intentionally omitted <==

Thursday 13[th] June 2019

ASX Announcement – MICRO-X LIMITED (ASX: MX1)

RESEARCH AND DEVELOPMENT INCENTIVE SECURED LOAN DRAWDOWN

Micro-X Limited (‘ Micro-X’ ) is pleased to provide an update on the forward financing facility of $3.0M secured against Micro-X’s projected FY2019 AusIndustry R&D Tax Incentive refund that was announced on 30[th] April 2019.

The remaining drawdown of $1.5M which was subject to the completion of due diligence has been approved and received into our bank account on 12[th] June 2019.

For further information please contact:

Mr Peter Rowland Managing Director, Micro-X Limited Telephone: +61 418 844 981 [email protected] www.micro-x.com

About Micro-X : Micro-X Limited (“ MX1 ”) is an Australian Securities Exchange listed company developing and commercialising a range of highly innovative products based on proprietary carbon nanotube emitter technologies exclusively licensed and sourced from XinRay Systems Inc., a US based technology developer. These technologies enable the miniaturisation of a number of X-ray applications relevant to large global markets.

The Company has three initial products in its development pipeline – a mobile medical x-ray imager for hospitals, a version for deployed military use and a mobile security back-scatter imager. It is establishing manufacturing for these products in an ISO13485 certified facility in Tonsley, South Australia.